@article {89,
	title = {Peripheral blood stem cell apheresis for allogeneic transplants: Ibni Sina experience},
	journal = {Transfusion \& Apheresis Science},
	volume = {30},
	year = {2004},
	note = {HPC Check},
	pages = {189 - 91},
	abstract = {BACKGROUND: The rate of utilizing peripheral blood stem cells (PBSC) as a source for allogeneic stem cells is growing rapidly. We aimed to demonstrate our 4 years experience as the largest apheresis center in Turkey and analyzed the content of the apheresis material. PATIENTS AND METHODS: From 1998 to the end of April 2002, 151 leukopheresis procedures were performed on 116 healthy donors (M/F:66/50) with a median age of 30 years (14-53). The HLA identical sibling donors received rhG-CSF 10 microg/kg/day sc. for 4 days and at the 5th day leukopheresis was started until collecting >4 x 10e6/kg CD34+ cells. Two times the donors{\textquoteright} total blood volume was processed in 195 min (178-245) on continuous flow cell separators using peripheral venous access. RESULTS: Preapheresis WBC was 51.5 x 10e9/L (range, 13.11-91.3). Mono nuclear cell, CD34 and CD3 quantity of the harvest material were 5.35 x 10e8/kg (range, 0.45-23.46), 6.4 x 10e6/kg (range, 2.49-33.27) and 2.79 x 10e8/kg (range, 0.46-30.95), respectively. We were able to reach the target CD34 count after 1st cycle in 39\% and 2nd cycle 61\% of the procedures. In all donors with a peripheral blood CD34 count >80/mcl we succeeded to collect enough stem cells with only one leukopheresis. CONCLUSION: Collection of peripheral blood stem cells with continuous flow cell separators is well tolerated, with no mobilization failures or poor mobilizers. We collected high values of CD34+ cells (med. 6.4 x 10e6/kg) at the expense of high CD3+lymphocytes (med. 2.79 x 10e8/kg), which may increase the risk of acute and chronic GVHD after allogeneic hemapoietic cell transplantation.},
	keywords = {*Blood Donors, *Hematopoietic Stem Cell Transplantation / mt [Methods], *Leukapheresis / mt [Methods], *Leukapheresis / sn [Statistics \& Numerical Data], Adolescent, Adult, Antigens, CD3 / an [Analysis], Antigens, CD34 / an [Analysis], Blood Donors / sn [Statistics \& Numerical Data], Female, Granulocyte Colony Stimulating Factor, Recombinant / ad [Administration \& Dosage], Hematopoietic Stem Cells / im [Immunology], Humans, Leukocytes / im [Immunology], Male, Middle Aged, Prospective Studies, Transplantation, Homologous, Turkey},
	author = {Arat,M. and Arslan,O. and Ayyildiz,E. and Topcuoglu,P. and Dalva,K. and Ilhan,O.}
}
